Genmab A (GMAB) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access GMAB Annual Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Genmab A finances operations and invests in assets.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash And Cash Equivalents269.48
Cash & Short-term Investments269.00
Accounts receivable15.08
Trade & Other Current Receivables (IFRS combined total)1,112.00
Inventories2.83
Inventories0.00
Other Current Assets0.00
Total Current Assets453.33
Equipment/Property/Plant Net24.04
Goodwill net55.78
Intangible Assets1,433.53
Other Assets, Noncurrent222.03
Total Assets2,022.78
Liabilities
Longterm Borrowings785.83
Other Liabilities, Current0.00
Total Current Liabilities224.23
Total Long-term Debt0.00
Deferred Tax Liabilities, Net LI57.20
Other liabilities, Noncurrent261.00
Total Liabilities1,104.02
Stockholders' Equity
Other Equity5,713.00
Common Stockholder's Equity918.76
Total Stockholder's Equity918.76
Liabilities & Stockholder's Equity2,022.78
4 historic quarters locked

Sign in to unlock the full Genmab A balance sheet history.

About Genmab A s Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001434265-26-000014

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.